Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Lykera Biomed S.A.
DescriptionHumanized mAb against S100 calcium binding protein P (S100P)
Molecular Target S100 calcium binding protein P (S100P)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today